
Publications
ALK-001 (C20-D3-Vitamin A) slows the growth of atrophic lesions in ABCA4-related Stargardt Disease: Results of a Phase 2 placebo-controlled clinical trial (TEASE study)
June 1, 2022
C20D3-Vitamin A Prevents Retinal Pigment Epithelium Atrophic Changes in a Mouse Model
December 1, 2021
Vitamin A cycle byproducts impede dark adaptation
September 1, 2021
TEASE: a phase 2 clinical trial assessing the tolerability and effects of oral once-a-day ALK-001 on Stargardt disease
September 1, 2016
Can Vitamin A be Improved to Prevent Blindness due to Age-Related Macular Degeneration, Stargardt Disease and Other Retinal Dystrophies?
January 1, 2016
The Rate of Vitamin A Dimerization in Lipofuscinogenesis, Fundus Autofluorescence, Retinal Senescence and Degeneration
January 1, 2016
Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization
October 7, 2015
Morphological and physiological retinal degeneration induced by intravenous delivery of vitamin A dimers in rabbits
February 1, 2015